Kerry Lamont Lee

Q: What Schools Are Affiliated With Kerry Lamont Lee

Kerry Lamont Lee is affiliated with the following schools: University of Vermont, Université de Montréal, Uppsala University, University of Minnesota, Johns Hopkins University, University of Barcelona, Baylor University, Duke University

Kerry Lamont Lee's AcademicInfluence.com Rankings

Kerry Lamont Lee

Philosophy

#8390

World Rank

#11764

Historical Rank

Logic

#5426

World Rank

#6826

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Kerry Lamont Lee's Degrees

Doctorate Medicine Stanford University
PhD Biomedical Sciences Stanford University

Why Is Kerry Lamont Lee Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kerry Lamont Lee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. (2005) (5925)
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. (2009) (1771)
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2003) (1486)
Rhythm control versus rate control for atrial fibrillation and heart failure. (2008) (1406)
Prognostic importance of defibrillator shocks in patients with heart failure. (2008) (1341)
Outcomes of anatomical versus functional testing for coronary artery disease. (2015) (1126)
Diuretic strategies in patients with acute decompensated heart failure. (2011) (1069)
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. (2013) (1013)
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. (2002) (892)
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months (1994) (844)
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019) (800)
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. (2012) (752)
Myocardial viability and survival in ischemic left ventricular dysfunction. (2011) (745)
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) (2003) (694)
Coronary bypass surgery with or without surgical ventricular reconstruction. (2009) (646)
Type A Behavior, Hostility, and Coronary Atherosclerosis* (1980) (608)
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. (2016) (606)
Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease (1993) (516)
Coronary-artery bypass surgery in patients with left ventricular dysfunction. (2011) (478)
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator (2013) (475)
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. (2013) (417)
Early versus delayed, provisional eptifibatide in acute coronary syndromes. (2009) (406)
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. (2007) (373)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019) (332)
Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial (1991) (306)
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) (2017) (292)
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (2006) (271)
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial (2018) (260)
Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia (1998) (252)
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial (2000) (252)
Quality of life with defibrillator therapy or amiodarone in heart failure. (2008) (245)
Use of Aortic Counterpulsation to Improve Sustained Coronary Artery Patency During Acute Myocardial Infarction: Results of a Randomized Trial (1994) (244)
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. (2002) (236)
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data (2006) (233)
Home use of automated external defibrillators for sudden cardiac arrest. (2008) (231)
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. (2007) (229)
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population (2009) (224)
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial (2009) (220)
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. (2013) (215)
A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction (1992) (213)
Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial (2002) (209)
Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial (2012) (206)
Clinical implications of chronic heart failure phenotypes defined by cluster analysis. (2014) (192)
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. (2007) (190)
Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy (2008) (190)
Effects of long-term estrogen replacement therapy: II. Neoplasia (1979) (189)
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. (2006) (188)
Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction: The HF-ACTION Predictive Risk Score Model (2012) (186)
Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction (1997) (186)
Electrocardiographic Predictors of Arrhythmic Death and Total Mortality in the Multicenter Unsustained Tachycardia Trial (2004) (184)
Complications arising after implantation of DDD pacemakers: the MOST experience. (2003) (176)
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study (2005) (173)
Prediction of Long-Term Outcomes by Signal-Averaged Electrocardiography in Patients With Unsustained Ventricular Tachycardia, Coronary Artery Disease, and Left Ventricular Dysfunction (2001) (172)
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). (2002) (172)
Risk of Thromboembolism in Heart Failure: An Analysis From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (2007) (169)
Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion (1993) (168)
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. (2013) (167)
Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial (2005) (167)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study (2015) (166)
Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. (2017) (157)
Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. (2013) (155)
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2008) (152)
Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure (2013) (147)
Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial (1995) (146)
Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes (2002) (144)
Ejection Fraction Response to Exercise in Patients with Chest Pain and Normal Coronary Arteriograms (1981) (138)
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure (2021) (135)
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. (2010) (131)
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. (2019) (125)
Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction (2018) (123)
One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial (1996) (122)
PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. (2014) (120)
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy. (2016) (120)
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). (2004) (118)
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. (2012) (115)
Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. (2005) (115)
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. (2016) (112)
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design (2018) (106)
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. (2012) (106)
Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) (2017) (105)
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. (2008) (104)
Thyroid function in heart failure and impact on mortality. (2013) (102)
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy (1991) (100)
Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) (2016) (96)
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. (2013) (95)
Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2007) (92)
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials (2015) (90)
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. (2014) (88)
Patient-Specific Predictions of Outcomes in Myocardial Infarction for Real-Time Emergency Use: A Thrombolytic Predictive Instrument (1997) (88)
The Effect of an EDTA-based Chelation Regimen on Patients With Diabetes Mellitus and Prior Myocardial Infarction in the Trial to Assess Chelation Therapy (TACT) (2014) (88)
The Prognostic Value of Coronary Artery Calcium in the PROMISE Study (2017) (86)
Observational Comparison of Event‐Free Survival With Medical and Surgical Therapy in Patients With Coronary Artery Disease: 20 Years of Follow‐up (1992) (86)
Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial (2004) (85)
Identification of Patients With Coronary Disease at High Risk for Loss of Employment: A Prospective Validation Study (1992) (83)
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study (2001) (82)
Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). (2007) (82)
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). (2006) (81)
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. (2020) (80)
Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. (2014) (79)
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. (2013) (79)
Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial (2002) (78)
Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial (2008) (78)
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. (2014) (77)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The EXACT-HF Study (2015) (75)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (2005) (75)
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis (2017) (74)
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. (2005) (73)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada: Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I (2004) (72)
Design of the Trial to Assess Chelation Therapy (TACT). (2012) (70)
Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. (2013) (70)
Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. (2012) (70)
Systematic adjudication of myocardial infarction end-points in an international clinical trial (2001) (70)
A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Results From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial (2010) (69)
Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease. (2016) (69)
Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial (2017) (68)
Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2015) (67)
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. (2003) (67)
Effect of &bgr;-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) (2002) (67)
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. (2002) (64)
Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. (2012) (62)
Systolic Left Ventricular Function After Reperfusion Therapy for Acute Myocardial Infarction An Analysis of Determinants of Improvement (1993) (62)
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial. (2011) (60)
Effects of Coronary Angioplasty, Coronary Bypass Surgery, and Medical Therapy on Employment in Patients with Coronary Artery Disease: A Prospective Comparison Study (1994) (60)
Ejection Fraction Response to Exercise in Patients with Chest Pain, Coronary Artery Disease and Normal Resting Ventricular Function (1982) (59)
Effects of long-term estrogen replacement therapy: 1. Metabolic effects. (1979) (58)
Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death (2008) (58)
No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial. (2013) (57)
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction (2005) (55)
Oral High-Dose Multivitamins and Minerals After Myocardial Infarction (2013) (55)
Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2013) (55)
Predictors of stroke in patients paced for sick sinus syndrome. (2004) (54)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure (2017) (53)
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2008) (53)
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. (2015) (53)
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%. (2010) (52)
Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) (2008) (52)
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. (2005) (51)
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. (2007) (50)
Effects of long-term estrogen replacement therapy: 2. Neoplasia. (1979) (50)
Nonsustained Ventricular Tachycardia in Coronary Artery Disease: Relation to Inducible Sustained Ventricular Tachycardia (1996) (49)
Understanding the Role of P Values and Hypothesis Tests in Clinical Research. (2016) (48)
A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery. (2005) (47)
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2008) (47)
Multivariate Tests for Clusters (1979) (44)
International variation in the use of evidence-based medicines for acute coronary syndromes. (2003) (43)
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. (2019) (42)
The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. (2017) (42)
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. (2009) (42)
Holding GUSTO Up to the Light (1994) (41)
EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. (2014) (41)
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure? (2004) (40)
Association of Prolonged QRS Duration With Death in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2005) (40)
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2011) (39)
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). (2014) (39)
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997) (38)
Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease (2016) (38)
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (2011) (38)
Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2014) (34)
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2007) (34)
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). (2013) (33)
Clinical and Quality of Life Comparison of Accelerometer, Piezoelectric Crystal, and Blended Sensors in DDDR‐Paced Patients with Sinus Node Dysfunction in the Mode Selection Trial (MOST) (2005) (32)
Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial (2016) (32)
Absence of bilateral vision loss from amiodarone: a randomized trial. (2007) (32)
Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. (2016) (30)
Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee. (2006) (30)
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials (2017) (30)
Influence of Crossover on Mortality in a Randomized Study of Revascularization in Patients With Systolic Heart Failure and Coronary Artery Disease (2013) (30)
Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. (2015) (30)
Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks (2003) (29)
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease. (2009) (29)
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. (2019) (29)
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients: Design and Rationale of the EXACT-HF Study (2013) (28)
Safety and Efficacy of a Subcutaneous Implantable-Defibrillator (2012) (28)
Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Biomarker Substudy of the Surgical Treatment for Ischemic Heart Failure Trials (2013) (28)
Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial (2013) (28)
More on the GUSTO Trial (1994) (28)
Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow‐up from the STICH trial (2015) (27)
Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure) (2018) (27)
Thrombolysis and angioplasty in acute myocardial infarction. (1988) (26)
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). (2004) (26)
Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. (2006) (25)
Method for Establishing Authorship in a Multicenter Clinical Trial (2009) (25)
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. (2015) (25)
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial (2014) (24)
Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial (2017) (24)
Abstract 2113: T-Wave Alternans SCD HeFT Study: Primary Endpoint Analysis (2006) (23)
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2004) (23)
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. (2020) (23)
The STICH trial: evidence‐based conclusions (2010) (23)
CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. (2015) (22)
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial (1997) (22)
Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. (2014) (22)
Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT) (2012) (22)
Prognostic Significance of Nonsustained Ventricular Tachycardia Identified Postoperatively After Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction (2002) (22)
Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes (2018) (22)
From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP). (2006) (21)
AB24-2: Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT (2006) (21)
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial (2021) (21)
Hemodynamic effects of the antiarrhythmic drug pirmenol (1982) (21)
Predictive Model for High-Risk Coronary Artery Disease: Insights From the PROMISE Trial (2019) (21)
Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. (2017) (20)
Predicting appropriate shocks in patients with heart failure: Patient level meta‐analysis from SCD‐HeFT and MADIT II (2016) (20)
Death in patients with permanent pacemakers for sick sinus syndrome. (2003) (20)
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction (2002) (18)
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2014) (18)
Mode of Induction of Ventricular Tachycardia and Prognosis in Patients with Coronary Disease: The Multicenter UnSustained Tachycardia Trial (MUSTT) (2008) (17)
Relationship between Regional Myocardial Procainamide Concentration and Regional Myocardial Blood Flow during Ischemia in the Dog (1978) (17)
The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT). (2019) (17)
An age‐ and sex‐specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial (2017) (17)
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates. (2018) (16)
Using observational data to estimate prognosis: an example using a coronary artery disease registry (2001) (16)
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. (2007) (16)
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. (2013) (16)
Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial (2016) (15)
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). (2007) (15)
Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: a nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION); design and rationale. (2007) (15)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada (2004) (14)
The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT) (2005) (14)
Extent of Coronary and Myocardial Disease and Bene ﬁ t From Surgical Revascularization in LV Dysfunction (2014) (14)
Adverse Effects of First‐Degree AV‐Block in Patients with Sinus Node Dysfunction: Data from the Mode Selection Trial (2013) (13)
Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. (2012) (13)
Lessons Learned From a Clinical Trial (2004) (13)
Independent data monitoring committees: preparing a path for the future. (2014) (13)
Rationale and design of the Home Automatic External Defibrillator Trial (HAT). (2008) (12)
Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure) (2017) (12)
Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. (2016) (12)
The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial (2018) (12)
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). (2009) (11)
The Exclusion of Women from Clinical Trials of Thrombolytic Therapy (1995) (10)
AB19-5: Mortality after appropriate and inappropriate shocks in SCD-HeFT (2006) (10)
Towards a new order in cardiovascular medicine: re-engineering through global collaboration. (2010) (10)
Response to letters regarding article, "role of microvolt t-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction (2009) (10)
Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial (2014) (9)
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial (2022) (9)
Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results. (2015) (9)
Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial (2005) (9)
Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. (2010) (9)
Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia (2019) (9)
889-6 A simple model using the MUSTT database can stratify total mortality and sudden death risk of coronary disease patients (2004) (9)
DISCORDANCES BETWEEN PREDICTED AND ACTUAL RISK OF ADVERSE EVENTS IN OBESE PATIENTS WITH SUSPECTED CARDIAC ISCHEMIA: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (8)
Disagreement between site investigators and clinical event committees is common and can affect trial results (1998) (8)
Predicting survival from the coronary arteriogram: an experience-based statistical index of coronary artery disease severity (2002) (8)
The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). (2006) (8)
DISCORDANCES BETWEEN PREDICTED AND ACTUAL RISK OF ADVERSE EVENTS IN OBESE PATIENTS WITH SUSPECTED CARDIAC ISCHEMIA: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (8)
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT). (2010) (7)
Restenosis after angioplasty: Overview of clinical trials using aspirin and omega-3 fatty acids (1990) (7)
Equivalence and noninferiority trials (2000) (6)
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation (2021) (6)
Abstract 2428: Patients Who Receive an Implantable Cardioverter Defibrillator for MADIT-II Criteria in Clinical Practice are Different From Patients Enrolled in MADIT-II (2007) (6)
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? (2014) (6)
IMPACT OF SURGICAL VENTRICULAR RECONSTRUCTION ON SPHERICITY INDEX IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: FOLLOW-UP FROM STICH TRIAL (2014) (5)
755-5 Risk Factors for Stroke Following Thrombolytic Therapy: Case-Control Study from the GUSTO Trial (1995) (5)
Abstract 1872: Beta Blocker (BB) Use Was Associated with Reduced Atrial Fibrillation (AF) and Flutter (AFL) in the Sudden Cardiac Death Heart Failure Trial (SCD-HeFT) (2006) (5)
Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial (2017) (5)
Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial (2017) (5)
Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial. (2019) (4)
Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America (2017) (4)
Chelation therapy and cardiovascular outcomes--in reply. (2013) (4)
AB19-1: Decreased impact of implantable defibrillators on sudden cardiac death in patients with renal insufficiency and heart failure: An analysis of the SCD-HeFT (2006) (4)
Renal function and coronary bypass surgery in patients with ischemic heart failure. (2020) (4)
SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS (2014) (4)
Rhythm precursors in those treated for ventricular tachycardia or ventricular fibrillation in SCD-HeFT (2005) (4)
The Practical Value of Logistic Regression (2010) (4)
Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
Differential Impact of Mitral Valve Repair on Outcome of Coronary Artery Bypass Grafting with or without Surgical Ventricular Reconstruction in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2019) (3)
Comparison of Effects of Abciximab Versus Eptifibatide on C-Reactive Protein, Interleukin-6, and Interleukin- 1 Receptor Antagonist After Coronary Arterial Stenting (2003) (3)
Prediction of reocclusion after successful reperfusion during acute myocardial infarction (1991) (3)
Survival in single vessel coronary disease (1982) (3)
SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION (2011) (3)
Assessment of the Pulmonary Vascular Bed by Echocardiographic Right Ventricular Systolic Time Intervals (2005) (3)
Effect of high‐dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) (2018) (3)
Abstract 18053: Prognostic Value of Anatomic versus Functional Diagnostic Testing in Symptomatic Patients With Suspected CAD: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (3)
Some statistical tests for clusters (1975) (2)
A Database Approach for Stabilizing Clinical Decisions in the Setting of Chronic Illness (1979) (2)
Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply. (2019) (2)
Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial. (2013) (2)
SEX DIFFERENCES IN DEMOGRAPHICS, RISK FACTORS AND PRESENTATION IN STABLE CONTEMPORARY OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROMISE TRIAL (2016) (2)
OUTCOMES IN PATIENTS WITH DIABETES MELLITUS AND SUSPECTED CORONARY ARTERY DISEASE FOLLOWING NON-INVASIVE TESTING: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (2)
Abstract 16636: Left Ventricular Function and Remodeling Early After Coronary Artery Bypass Grafting Compared With Medical Therapy: Results From the Surgical Treatment for Ischemic Heart Failure (STICH)Trial (2014) (2)
EFFECT OF ADMISSION ORAL DIURETIC DOSE ON RESPONSE TO CONTINUOUS VERSUS BOLUS INTRAVENOUS DIURETICS IN ACUTE HEART FAILURE: AN ANALYSIS FROM DOSE-AHF (2011) (2)
Abstract 3625: Do Patients Who Meet SCD-HeFT Criteria in Clinical Practice Differ from Patients Enrolled in SCD-HeFT? (2007) (2)
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale (2003) (2)
Sex Differences in Functional Stress Test Versus CT Angiography in Symptomatic Patients With Suspected CAD : Insights From PROMISE (2016) (2)
EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIAL (2014) (2)
P73 Comparison of investigator and central events review of myocardial infarction rates as a means to improve events classification: Results from GUSTO-IIa (1996) (2)
Identification of Patients With Coronary Disease (2005) (2)
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT). (2020) (2)
Abstract 19392: A Landmark Analysis of 30-day Mortality after Coronary Artery Bypass Surgery in Patients with Ischemic Heart Failure: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2014) (2)
Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. (2017) (2)
Abstract Tenth annual meeting of the society for clinical trials May 15–18, 1989 Hyatt Regency Minneapolis, Minneapolis, MinnesotaUse of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction (1989) (2)
A47 Differences in endpoint identification by investigators versus independent review (1996) (2)
SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH OVERALL MORTALITY (2011) (2)
DIFFERENTIAL OUTCOMES WITH CHELATION THERAPY AMONG PATIENTS WITH ANTERIOR VERSUS NON-ANTERIOR MYOCARDIAL INFARCTION: A TACT SUBSTUDY (2014) (2)
Randomisation in the SYMPHONY trial (2000) (1)
Lessons from a Simulated Randomized Trial in Coronary Artery Disease (2005) (1)
FACTORS INFLUENCING EXERCISE PARTICIPATION IN CARDIAC PATIENTS (1993) (1)
Abstract 14889: Inducible Myocardial Ischemia and Outcomes in Patients with Coronary Artery Disease and Left Ventricular Dysfunction Treated with Medical Therapy or Surgical Revascularization. A Report from the STICH Trial (2012) (1)
Are the results of the multicenter automatic defibrillator implantation trial-II applicable to patients seen at a tertiary referral center? (2003) (1)
Abstract 11546: Clinical Benefit of EDTA Chelation Therapy in Patients With Diabetes in the Trial to Assess Chelation Therapy (TACT) (2013) (1)
Factors and outcomes associated with improved left ventricular systolic function in patients with cardiomyopathy (2020) (1)
PHYSICIAN JUDGMENT MORE ACCURATE THAN DIAMOND-FORRESTER RISK SCORE IN PREDICTING OBSTRUCTIVE CAD AND ADVERSE CARDIAC EVENTS IN PATIENTS WITH CHEST PAIN: INSIGHTS FROM THE PROMISE TRIAL (2018) (1)
MARKERS OF CONGESTION, SYMPTOM RELIEF AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE: DATA FROM THE DIURETIC OPTIMAL STRATEGY EVALUATION IN ACUTE HEART FAILURE STUDY (2011) (1)
Continuing evolution of treatment strategy and outcome for coronary artery disease: observational data 1986–2000 (2002) (1)
DOES SEVERITY OF LEFT VENTRICULAR REMODELING INFLUENCE THE RELATION BETWEEN MYOCARDIAL VIABILITY AND SURVIVAL WITH MEDICAL OR SURGICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION (2014) (1)
Abstract 18819: Graded Benefit of EDTA Chelation in Post-MI Patients with Diabetes Treated with Different Hypoglycemic Strategies (2014) (1)
Abstract Seventeenth annual meeting of the society for clinical trialP29 Prognostic significance of cardiac enzyme elevations detected through systematic screening in clinical trials (1996) (1)
Abstract 14051: Changes in Medical Therapy and Lifestyle After Anatomical Versus Functional Testing for Coronary Artery Disease: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (1)
Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST). (2006) (1)
Cystatin C as a Biomarker of Worsening Renal Function in Acute Heart Failure: Insights from the DOSE Study (2011) (1)
Abstract 10476: Effect of High-dose Oral Multi-vitamins and Minerals in Patients Not Treated With Statins in the Trial to Assess Chelation Therapy (2015) (1)
Coronary bypass vs medicine: Problems and guidelines in assessing mortality differences (1981) (1)
Opportunities for Enhancing the Use of Evidence-Based Medicines for Acute Coronary Syndromes: Insights From the Symphony Studies (2002) (1)
Partitioning the effects of concomitant variables in survival analysis (1975) (1)
Abstract 322: SPECT Myocardial Perfusion Imaging and the Risk of Sudden Cardiac Death in Patients With Coronary Disease and Left Ventricular Ejection Fraction >35% (2009) (1)
DETERMINANTS OF MORBIDITY AND MORTALITY IN CHRONIC HEART FAILURE (CHF) WITH SYSTOLIC DYSFUNCTION: RESULTS OF THE HF-ACTION PREDICTIVE MODEL (2010) (1)
Outcomes for Patients with Anterior Myocardial Infarction and Prior Cardiac Arrest in the Home Automated External Defibrillator Trial (HAT). (2021) (1)
Abstract 10466: Post-myocardial Infarction Treatment With Edetate Disodium was Safe in the Trial to Assess Chelation Therapy (2015) (1)
Differential outcomes with edetate disodium-based treatment among stable post anterior vs. non-anterior myocardial infarction patients. (2020) (1)
Surgical therapy for coronary disease: randomized and observational studies. (1990) (1)
Abstract 11054: Clinical Benefit of EDTA-based Chelation Therapy and High-dose Oral Multivitamins and Multiminerals in TACT- An Expanded Comparison of 2 Factorial Groups (2013) (1)
Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients. (2014) (1)
Use of Computerized Statistical Models to Educate Medical Housestaff in Estimating Clinical Outcomes (1987) (1)
Thrombolytic therapy for women with acute myocardial infarction: is there a gender gap? (1995) (0)
Abstract 15982: Impact of Baseline Right Ventricular Dysfunction on the Effect of Adding Ventricular Reconstruction to Surgical Revascularization in Patients with Ischemic Cardiomyopathy. Insights from STICH trial (2012) (0)
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial (2023) (0)
Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial” (2010) (0)
Abstract 14364: External Validation of the CAD Consortium Prediction Models for the Presence of Coronary Artery Disease in Patients With Stable Chest Pain (2016) (0)
P2-75: Events: Designation & distribution in the Multicenter UnSustained Tachycardia Trial (MUSTT) (2006) (0)
PATTERNS OF PREVENTIVE MEDICAL THERAPY AND LIFESTYLE PRACTICES IN PATIENTS EVALUATED FOR SUSPECTED CORONARY ARTERY DISEASE: THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2016) (0)
Publication Criteria for Statistical Prediction Models (1993) (0)
InnaTtance of Thromboeyk Phase Afte ' ~ Adminl & traflon of ° hro (2016) (0)
Prognostic/Clinical Prediction Models: Using Observational Data to Estimate Prognosis: An Example Using a Coronary Artery Disease Registry (2005) (0)
coronary artery disease Incremental value of the exercise test for diagnosing the presence or absence of (2011) (0)
lectrocardiographic dictive of Successf (1990) (0)
Abstract 12202: New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials (2016) (0)
Abstract 10999: CHADS2 and CHA2DS2-VASc scores are Predictive of Adverse Cardiovascular Outcomes in All Patients, Not Just Those With a Diagnosis of AF: an Analysis of the 2010 Patients From the MOST Trial (2013) (0)
Clinical Predictors of Antiarrhythmic Drug Response in the MUSTT Trial (1998) (0)
Comparison of Differences in Outcome After Percutaneous Coronary Intervention in Men Versus Women <40 Years of Age (2004) (0)
P71 Impact of the clinical events committee process on data safety monitoring (1996) (0)
Analysis intheTAMI7Study Performance ofa Noninvasive MethodforReal-Time Detection ofFailed Myocardial Reperfusion (2011) (0)
Abstract 18178: Cause-Specific Mortality in Patients with Prior Anterior Myocardial Infarction: Clinical Predictors Identified in the Home Automated External Defibrillator Trial (2010) (0)
Escalating diuretic strategy beats ultrafiltration in decompensated heart failure (2013) (0)
P2-78: Circadian variation of ventricular arrhythmias in SCD-HeFT (2006) (0)
Abstract 16818: Circulating Cardiac Troponin I as Detected By a High-Sensitivity Assay among Patients Hospitalized with Acute Decompensated Heart Failure (2011) (0)
Appropriate outcome measures in trials evaluating treatment of atrial fibrillation (2000) (0)
Abstracts: Ventricular Fibrillation Induction at implant: hot issues (2009) (0)
The MANTRA II study – Authors' reply (2005) (0)
Abstract 18783: Predictive Model for High-Risk Coronary Artery Disease: An Analysis From PROMISE (2016) (0)
THERAPY AND PREVENTION (2005) (0)
Abstract 4095: Maintenance of Sinus Rhythm Is Not Associated with Improved Survival in Patients with Atrial Fibrillation and Heart Failure (2008) (0)
The association of the heart failure score with mortality and hospitalizations in pacemaker patients (2003) (0)
P65 Considerations for a group sequential, dose-response trial design (1993) (0)
Randomized Clinical Trials in HFpEF (2012) (0)
Plasma Angiotensin-Converting Enzyme Activity and Carotid Wall Thickening (2005) (0)
A Randomized Trial of Intravenous Heparin in 12 (Anisoylated Plasminogen Streptokinas Complex) in Nuae Myocardial Infarction : The Duke Clinical Cardiology Study (_1J_CCS) I 11action With Activator University THE DUCCS GROUP* (2016) (0)
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. (2022) (0)
CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial. (2021) (0)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I of declining mortality (2004) (0)
Abstract 2482: Quantification of Myocardial Scar Using a Simple ECG Tool Identifies Patients at Risk for Sudden Arrhythmic Death: An Analysis of SCD-HeFT (2009) (0)
Abstract 16630: Clinical Benefit of Chelation Therapy in Post-MI Patients With Diabetes and Peripheral Artery Disease (2014) (0)
Changing Efficacy of Coronary Revascularization (2005) (0)
A44 Reducing patient withdrawals in a large multi-center clinical trial (1993) (0)
Noninvasive FFR Derived From CoronaryCT Angiography (2017) (0)
IDENTIFYING STABLE CHEST PAIN PATIENTS WITH SUSPECTED CORONARY DISEASE IN WHOM NONINVASIVE TESTING MAY BE SAFELY DEFERRED: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2016) (0)
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty (2005) (0)
Abstract 10369: Safety of Anatomic versus Functional Diagnostic Testing: Insights From the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (0)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureHF-ACTION Randomized Controlled Trial (2009) (0)
1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation (2004) (0)
Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial (2014) (0)
SCD-HEFT: TURBULENCE SLOPE AND FRACTAL INFORMATION FROM BASELINE HOLTER MONITORING MAY AVOID UNNECESSARY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY DESPITE HEART FAILURE (2013) (0)
Do ICDs alter the location of death in heart failure patients (2005) (0)
A46 Patient self-addressed postcard follow-up is inadequate: Results from the Duke Clinical Research Institute (1996) (0)
484Impact of AF type on the outcome of atrial fibrillation ablation: insights from the CABANA trial (2019) (0)
Abstract 2140: Infrequent Need for Pacing Following Implantable Cardioverter-Defibrillator Shocks: Analysis of the Sudden Cardiac Death in Heart Failure Trial (2008) (0)
Atrial Fibrillation Maintenance of Sinus Rhythm and Survival in Patients With Heart Failure and (2012) (0)
Predictors of the ejection fraction response to exercise in patients with coronary artery disease (1982) (0)
cAn Official Journal oftheeAmerican Heart cAssociation, Inc. CLINICALINVESTIGATION (1984) (0)
An Analysis of Determinants of Improvement: Systolic Left Ventricular Function After Reperfusion Therapy for Acute Myocardial Infarction (1993) (0)
908-109 Incremental Prognostic Value of Electrocardiographic Findings when Added to Baseline Clinical Variables in Patients with Acute Myocardial Infarction (1995) (0)
AB19-3: Failure of spironolactone to reduce mortality or the need for an ICD in chronic moderate heart failure: Observations from the sudden cardiac death heart failure trial (2006) (0)
Higher T-Wave Amplitude Associated With Better Prognosis in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction (a GUSTO-I Substudy) 11This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California (1998) (0)
Abstract 1664: Impact of Ischemic Burden and Revascularization on Outcomes among Patients Receiving Drug Therapy Versus an Implantable Cardioverter Defibrillator in MUSTT: Evidence for Ischemia Induced Proarrhythmia (2007) (0)
A32 Simultaneous patient enrollment in multiple randomized trials: Experience in GUSTO (1993) (0)
Data management, design and implementation for the global utilization of streptokinase and t-PA for occluded coronary arteries study (1991) (0)
Strengthening Medical Device Postmarket Safety Surveillance (2017) (0)
TCT-284 Comparison of Visual Assessment of Coronary Stenosis with Independent Quantitative Coronary Angiography: Findings from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) (2015) (0)
·P-18 Need an endpoint for a clinical trial? Just ask (1990) (0)
A47 Statistical treatment comparisons for a trial of thrombolytic therapy in acute myocardial infarction (1993) (0)
Abstract 12580: Does Sex Influence the Effect of Surgical Revascularization in Patients in Ischemic Left Ventricular Dysfunction? Results From the STICH Trial (2016) (0)
Using experience to improve clinical decision making (1983) (0)
63 Clinical trials with dichotomous endpoints: Should we correct for baseline characteristics? (1997) (0)
Inﬂuence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy 13 , and Kerry L. Lee 2 , on behalf of the STICH Investigators (2012) (0)
Abstract 19621: Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing CABG: Results from the STICH trial (2014) (0)
Abstract 18647: Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial (2017) (0)
Antiarrhythmic drug use and mortality in pacemaker patients with sinus node dysfunction (2005) (0)
Patients With Systolic Heart Failure and Coronary Artery DiseaseClinical Influence of Crossover on Mortality in a Randomized Study of Revascularization (2013) (0)
Abstract 10721: Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction (2013) (0)
Abstract 16911: Behind the Looking Glass: Comparing Time to First Event versus Multiple Events Analyses in a Post-myocardial Infarction Clinical Trial (2015) (0)
A New Prognostic Treadmill Score Stratifies Risk in Outpatients (1990) (0)
Abstract 15545: Incremental Prognostic Value of Echocardiographic Markers of Left Ventricular Remodeling and Diastolic Function in the Surgical Treatment for Ischemic Heart Failure Trial (2014) (0)
Analysis of medical costs as a secondary end-point in a clinical trial (1991) (0)
Abstract 3162: Dynamic mortality modeling in PCI-treated ST-elevation Myocardial Infarction: Implications for Clinical Decision Making (2007) (0)
Rationale of the EXACT-HF Study Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients : Design and (2013) (0)
P2832Outcomes of catheter ablation for atrial fibrillation based on sex: data from the cabana trial (2019) (0)
INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE EFFICACY OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A META-ANALYSIS OF THREE RANDOMIZED TRIALS (2013) (0)
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease (2011) (0)
P2-69: Septadian variation in life-threatening ventricular arrhythmias in SCD-HeFT (2006) (0)
Abstract 14976: Influence of Myocardial Viability on the Outcome of Patients with Coronary Artery Disease and Left Ventricular Dysfunction Undergoing Coronary Bypass Surgery With and Without Surgical Ventricular Reconstruction: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) Tri (2012) (0)
Use of the 6-Min Walk Distance to IdentifyVariations in Treatment Benefits FromImplantable Cardioverter-Defibrillator andAmiodarone (2014) (0)
Abstract 11035: Worsening Renal Function in Hospitalized Heart Failure Patients with Preserved vs. Reduced Ejection Fraction (2010) (0)
Early Intravenous Heparin in Acute Myocardial Infarction (2005) (0)
EFFECT OF CHELATION THERAPY ON CARDIOVASCULAR EVENTS BY CHRONIC KIDNEY DISEASE STAGE: DATA FROM THE TRIAL TO ASSESS CHELATION THERAPY (TACT) (2014) (0)
Prognostic ValueofRadionuclide Angiography inMedically Treated Patients WithCoronary Artery Disease A Comparison WithClinical andCatheterization Variables (1990) (0)
AN AGE- AND SEX-SPECIFIC PERIPHERAL BLOOD GENE EXPRESSION SCORE CORRELATES WITH FUTURE CARDIOVASCULAR EVENTS: INSIGHTS FROM THE PROMISE TRIAL (2016) (0)
Abstract 3768: Thyroid Function and Mortality in the Sudden Cardiac Death in Heart Failure Trial (2006) (0)
Abstract 16626: Age-related Differences in Presentation and Assessed Risk of Suspected Coronary Artery Disease in the Clinic: Insights From the PROMISE Trial (2016) (0)
B-PO02-086 METHODS AND OUTCOMES FOR ABLATION IN THE CABANA TRIAL (2021) (0)
DOES OBESITY AFFECT RESPONSE TO TREATMENT IN ACUTE DECOMPENSATED HEART FAILURE? A DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) TRIAL SUBSTUDY (2011) (0)
3209High-risk coronary plaque is an independent predictor of major adverse cardiovascular events in patients with stable chest pain: Results from PROMISE (2017) (0)
The impact of implanting cardioverter-defibrillators in patients who meet the multicenter automatic defibrillator implantation trial-II criteria on the health care system at a tertiary referral center (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kerry Lamont Lee?

Kerry Lamont Lee is affiliated with the following schools: